CIK 0000728387
- Non-accelerated filer
- Smaller reporting company
Perspective Therapeutics, Inc.
Sign in to watch- Ticker
- CATX
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 411458152
- Phone
- +1 206-676-0900
- Business address
- 2401 ELLIOTT AVENUE, SUITE 320, SEATTLE, WA, 98121
- Former names
- IsoRay, Inc., Isoray, Inc., CENTURY PARK PICTURES CORP
- 4/A Insider Changes in Ownership
- 4/A Insider Changes in Ownership
- 4 Open-market buy Director bought 6,266 shares at an average $3.64 ($22,814)
- 4 Open-market buy Chief Financial Officer bought 12,829 shares at an average $3.82 ($48,974)
- 4 Open-market buy CEO bought 26,500 shares at an average $3.79 ($100,468)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Financial Officer bought 1,800 shares at $9.82 ($17,667)
- 4 Open-market buy Director bought 4,587 shares at an average $10.90 ($49,990)
- 4 Open-market buy CEO bought 100,000 shares at $1.17 ($117,430)
- 4/A Insider Changes in Ownership
- 4 Open-market buy Director bought 34,246 shares at $1.46 ($49,992)
- 4 Open-market buy Chief Financial Officer bought 25,006 shares at an average $1.40 ($35,007)
- 4 Open-market buy Director bought 55,000 shares at $1.38 ($75,900)
Page 3 of 17 · 339 filings